Video and game teaching to help children with sickle cell anemia
Tests video and game lessons on self-confidence and self-care in children with sickle cell anemia.
Plain-language title generated from the registry record
Registry title: Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease
Key facts
- Where
- Baghdad, IraqSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children with sickle cell anemia who can read and write. It tests educational methods (a video and a game) to help them manage their disease.
- Age
- 12-18 years (the registry also lists a minimum age of 11 years).
- Sex
- All sexes can join.
- Disease stage
- Sickle cell anemia, with no advanced complications such as multi-system organ damage.
Main reasons for not taking part
- History of mental illness
- Advanced complications of sickle cell disease, such as multi-system organ damage
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 11 and 18 years old?
Source: NCT07802210, who can take part
Where in Iraq
- Pediatric Hematology Center - Ibn Al-Baladi Maternity & Children Hospital and Hereditary Blood Diseases Center, Al-Karamah Teaching Hospital, Baghdad government.Baghdad, IraqNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Aula Ibrahim abd alrazak
- Trial code
- NCT07802210
- Record updated
- 3 September 2026
- Original description
Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025).Read full original descriptionShow less
Effectiveness of Innovative Educational Methods in Empowering Children With Sickle Cell Disease: A Randomized Controlled Trial
Sickle-cell disease (SCD) is a genetic disorder that affects hemoglobin, the molecule in red blood cells responsible for carrying oxygen. The disease causes red blood cells to become rigid and sickle-shaped, leading to blockages in blood flow and subsequent pain and organ damage (World Health Organization (WHO),2025).
Patients with sickle cell disease suffer from various complications of the disease during their lifetime, including anemia, sickle cell crises, acute chest syndrome, stroke, renal failure, retinal detachment and priapism. However, unforeseen and chronic pain crisis are the most common symptoms reported by the patients which are considered as the most common causes of referral to the emergency department and hospital to receive medical care in sickle cell patients (Poku, Atkin,\& Kirk,.2023).
Objective(s) of the study:
1. To evaluate the effectiveness of Innovative Educational Methods on self-efficacy in children with sickle cell anemia. 2. To evaluate the effectiveness of Innovative Educational Methods on self-care capacity in children with sickle cell anemia. 3. To find out the relationship between the effectiveness of Innovative Educational Methods on self-efficacy, self-care capacity and demographic characteristics of children with sickle cell anemia.
Inclusion: children with sickle cell anemia and visited Ibn Al-Baladi ,Al-Karamah center for hereditary blood diseases; age 12-18 years; being able to read and write; agrees and willing to participate in the study.
Exclusion: children who have a history of mental illness; children with advanced complications of SCD, such as multi-system organ damage.